Atidarsagene Autotemcel has 2 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Retrovir, Vaccines. Patients taking Atidarsagene Autotemcel should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Major
- 1
- Moderate
- 1
Major (1)
- Atidarsagene Autotemcel + Retrovir— Do not take anti-retroviral medications for at least one month prior to initiating stem cell mobilization. Anti-retrovir…
Moderate (1)
- Atidarsagene Autotemcel + Vaccines— Vaccination is not recommended during the 6 weeks preceding myeloablative conditioning and until hematological recovery …